doi: 10.23876/j.krcp.22.001 56 AstrupACarraroRFinerNHarperAKunesovaMLeanMEet al
In a retrospective study GLP-1 agonists have been shown to be associated with lower rates of hepatic decompensations compared to other glycemic agents, although more prospective data is needed
However, high doses of fiber supplements such as psyllium, glucomannan, or konjac may worsen gastrointestinal symptoms in people using GLP-1 medications
6 Dulaglutide (Trulicity): Mainly marketed as Trulicity in the US, dulaglutide has had FDA approval for type 2 diabetes management since 2014
10.1056/NEJMoa1612917 36 HolstJ
Primary Legal Claims in Filed Ozempic Lawsuits Against Novo Nordisk and Eli Lilly The core legal theories in the Ozempic litigation center on drug manufacturers fundamental duty to warn about known or reasonably foreseeable risks, with plaintiffs alleging systematic failures in safety communications dating back to the drugs initial approval